Multicenter Symphony IL-6 Monitoring Sepsis ICU Study
NCT06181604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143
Last updated 2025-08-03
Summary
The primary objective of this study is to establish an IL-6 concentration cutoff and optimal time point(s) for using Symphony IL-6 that predict 28-day mortality in patients who are admitted or are intended to be admitted to the intensive care unit (ICU) diagnosed with sepsis or septic shock.
Conditions
- Sepsis
- Septic Shock
Sponsors & Collaborators
-
Bluejay Diagnostics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-12
- Primary Completion
- 2024-07-12
- Completion
- 2024-07-12
Countries
- United States
Study Locations
More Related Trials
-
Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
NCT06915974 ·Status: RECRUITING ·Phase: NA
-
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126 ·Status: RECRUITING
-
POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock
NCT03953404 ·Status: UNKNOWN
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Cytokine Response in Septic Shock
NCT01770457 ·Status: UNKNOWN
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905 ·Status: COMPLETED
-
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
NCT06219135 ·Status: RECRUITING
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
NCT01724463 ·Status: UNKNOWN
-
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
NCT00034476 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock
NCT05921825 ·Status: UNKNOWN
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients
NCT02640807 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis
NCT07089524 ·Status: RECRUITING
-
CD64 and Antibiotics in Human Sepsis
NCT02922998 ·Status: COMPLETED
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA